Mars Inc., the confectionery, pet care, and food giant, has licensed Pairwise’s gene editing platform, called Fulcrum, to ...

The NC Biopharma Networking Group will host a networking event on August 19. Whether you are new to networking or a seasoned veteran, this is a great opportunity to make valuable connections within ...

BioSolveIT's Lunch-and-Learn Workshop will be held on August 18. This event is perfect for anyone interested in learning more about cutting-edge in-silico solutions for Medicinal and Computational ...

Precision BioSciences Inc., a clinical-stage company developing gene editing therapies for diseases with high unmet need, has received another pair of regulatory boosts. The FDA recently granted the ...

Among the many obstacles between idea and market in life sciences and biotechnology product development, the main challenge is securing capital. NCBiotech offers several business funding programs that ...

Struggling to identify types of roles you should apply for, or worried that your resume isn't up to snuff? Join our Career Development Network on August 21 from 12:30 to 2:30 p.m. for a presentation ...

Hatteras was founded in 2000 with the closing of Hatteras Venture Partners I, a seed-stage venture fund with $2.93 million in capital. Today, the firm is focused on seed- and early stage companies in ...

Bioventus, a Durham-based health care company, has received regulatory permission to begin marketing two medical devices that treat chronic pain. The U.S. Food and Drug Administration granted 510(k) ...

Walking inside a 2,500-square-foot laboratory in downtown Winston-Salem, visitors might not notice anything unusual. There are instruments, hoods, high-powered microscopes and other equipment you’d ...

Durham-based TruTechnologies has secured a strategic growth investment from LLR Partners to accelerate the expansion of its real-time clinical trial oversight solutions and fuel the next phase of ...